A clear trend in mRNA cancer vaccine development is the encapsulation of different mRNAs into the same LNP, simultaneously targeting diverse antigens.
← all excerpts
An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model.
1
—
—